发明名称
摘要 The present invention relates to compounds of formula (I) and their pharmaceutically acceptable salts, wherein R1, R2, R3 and Z are as defined herein, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders.
申请公布号 KR100420423(B1) 申请公布日期 2004.03.04
申请号 KR20007012039 申请日期 2000.10.28
申请人 发明人
分类号 C07D221/22;A61K31/435;A61K31/439;A61P1/00;A61P1/04;A61P3/04;A61P9/00;A61P9/10;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/34;A61P43/00 主分类号 C07D221/22
代理机构 代理人
主权项
地址